Skip to main content

Articles

Prostate Cancer, Conference Highlights ASCO
¹⁷⁷Lu-PSMA-617 Prolongs Survival in Patients with Metastatic Castration-Resistant Prostate Cancer
Phoebe Starr
Read More
Conference Highlights ASCO
Early Phase 3 Results Show Survival Benefit with Nivolumab-Based Regimens in Advanced Esophageal Squamous-Cell Cancer
Wayne Kuznar
Read More
Renal-Cell Carcinoma, Conference Highlights ASCO
Adjuvant Pembrolizumab Therapy Significantly Extends Disease-Free Survival in Patients with Clear-Cell Renal-Cell Carcinoma
Phoebe Starr
Read More
FDA Approvals, Select Drug Profiles
Opdivo First FDA-Approved Immunotherapy for First-Line Treatment of Advanced Gastric Cancer
Read More
FDA Approvals, Select Drug Profiles
Keytruda Received FDA Approval for First-Line Treatment of HER2-Positive Advanced Gastric Cancer
Read More
FDA Approvals, Select Drug Profiles
Trodelvy Receives New Indication for Advanced Urothelial Cancer
Read More
FDA Approvals, Select Drug Profiles
Sarclisa Receives New Indication for Relapsed or Refractory Multiple Myeloma
Read More
FDA Approvals, Select Drug Profiles
FDA Alert: Pepaxto (Melphalan Flufenamide) Associated with Increased Risk of Death in Postmarketing Clinical Trial
Read More
Industry Trends
Global Issues Driving US Healthcare Trends in 2021 and 2022
F. Randy Vogenberg, PhD; John Santilli, MBA
Read More
Perspectives
Concerns Related to Benefits and Harms of Real-World Shared Decision-Making for Lung Cancer Screening
James L. Mulshine, MD; David F. Yankelevitz, MD; Bruce Pyenson, FSA, MAAA
Read More
Page 18 of 246
Results 171 - 180 of 2458